1. Volume 131, Issue 4, Pages 1049-1056 (October 2006)
Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage 
Javier Fernández, Luis Ruiz del Arbol, Cristina Gómez, Rosa Durandez, Regina Serradilla, Carlos Guarner, Ramón Planas, Vicente Arroyo, Miguel Navasa 
Gastroenterology 
Volume 131, Issue 4, Pages (October 2006)
DOI: /j.gastro
Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

2. Figure 1
Flow diagram of patient allocation. More detailed information is shown in the text.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

3. Figure 2
Probability of remaining free of proved and possible infections (A) and proved infections (B) in patients receiving ceftriaxone (continuous line) and norfloxacin (dotted line). There were significant differences between groups.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

4. Figure 3
Probability of remaining free of spontaneous bacterial peritonitis or bacteremia in patients receiving ceftriaxone (continuous line) and norfloxacin (dotted line). There were significant differences between groups.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

5. Figure 4
Probability of remaining free of proved and possible infection (A) and proved infections (B) in patients at high risk for infection (blood transfusion requirements >2 units and/or failure to control bleeding) who received ceftriaxone (continuous line) or norfloxacin prophylaxis (dotted line). There were significant differences between groups.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions